norva
Best Pharmaceutical Partnership with the NHS 

How to enter

  1. Register an account.
  2. Start your entry (save it in-progress).
  3. Submit your entry to be in the running.

Best of luck!

Start your entry

The NHS increasingly works with medicines companies to deliver improved services to patients. Partnerships between trusts and the industry are varied and represent a range of projects, from access and treatment pathways to service and capacity improvements. As the NHS shifts care closer to home and works to embed prevention and medicines optimisation across the system, these partnerships have a growing role in supporting national priorities.

The judges will be looking for innovative projects which demonstrate best practice and deliver benefits which would have been impossible for the NHS to do by itself. They are likely to deal with a specific patient group and could include audit and data analysis, care co-ordination and new pathways for patients. As well as helping the NHS provide better services within financial constraints, they should offer ongoing benefits after any initial set up period. Crucially, they must add value and not just replicate something the NHS could do for itself.

This award is for partnerships led by a medicines company where the deliverable is about getting the right medicine to the right patient, such as prescribing optimisation, therapy-area pathway redesign or improving access to treatments, including through biosimilar adoption. Partnerships whose deliverable is a diagnostic, device, test, genomic service or body of evidence should enter the Life Sciences Partnership of the Year.

Eligibility

  • Medicines companies, including originator, generic and biosimilar manufacturers, supplying services in partnership with NHS organisations.
  • The deliverable should concern medicines, such as prescribing optimisation, therapy-area pathway redesign or improving access to treatments, including through biosimilar adoption
  • Single partnership or joint working projects • Any size of project may apply, and judges will be reviewing impact and efficacy.
  • Eligible projects should have shown clear results within the last two years up to the awards submission deadline

Ambition

The challenge and context within which your project, person or organisation is set alongside your goals and targets whether quantitative or qualitative, and how this aligns with national priorities. • 

  • Describe the clinical or service challenge the partnership addressed and why it stands out from similar work.
  • Set out the goals and targets agreed and how they aligned with NHS priorities such as the 10 Year Health Plan, the shift to neighbourhood and community care, medicines optimisation or the single national formulary.
  • Explain what made the partnership genuinely collaborative rather than business as usual.

Collaboration

The stakeholders’ involvement in co-designing and delivering the project. How have patients, staff at all levels, communities and other parties worked together to realise the outcomes?

  • Describe how the medicines partner and NHS teams worked together and how skills and knowledge were shared.
  • Explain the roles of those involved and how patients were engaged where relevant.
  • Provide evidence of a true partnership that enhanced NHS capability.

Impact

The measurable benefits delivered to patients, staff, your organisation or the wider system. Provide data and evidence showing improvements to outcomes, quality, access, equity or efficiency.

  • Provide measurable evidence of improved patient outcomes, access or medicines optimisation.
  • Share before-and-after data and testimonial evidence.
  • Demonstrate value for money and efficiency.

Scale

How your work has been shared, adopted or replicated beyond your immediate team or organisation. This includes dissemination through publications, presentations, toolkits, partnerships or inspiring similar initiatives elsewhere.

  • Describe how the approach has been adopted or adapted by other NHS organisations, and how scalability was planned for from the outset.
  • Explain how best practice and learning have been shared.

Sustainability

The potential for the project/work to continue and create lasting impact. Evidence of how it can be sustained or built upon. 

  • Describe how the benefits are sustained over time.
  • Explain how the partnership continues to add value.

Best Pharmaceutical Partnership with the NHS 

Start your entry

To find out more

Partnership opportunities:  Sponsorship Sales Team
Awards entry enquiries: Support Team
Judging and event management: Awards Support